Jeremy Sohn is the Vice President and Head of Digital Business Development & Licensing at Novartis, where he leads all digital, technology-driven business development initiatives. Jeremy also serves as the ad interim Global Head of Commercial Digital Medicines. Jeremy is a serial software entrepreneur with more than 17 years of experience founding, managing, and advising both healthcare and technology companies.
Prior to Novartis, Jeremy was Managing Director and Operating Partner at MPM Capital, where he led the firm’s digital health investment strategy and partnership with Novartis. While at MPM, he founded two companies, CentrosHealth, a mobile patient-engagement platform for patients during clinical trials, and TriNetX, a network of clinical data warehouses that optimizes clinical trial protocol design and patient recruitment.
Jeremy graduated from Princeton University’s Woodrow Wilson School of Public and International Affairs, with a focus on biotechnology and medical policy.